Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-04-07
1993-11-23
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514407, 514866, 5483661, A61K 31415
Patent
active
052644510
ABSTRACT:
The compound of the formula: ##STR1## in which the dotted lines represent two sites of unsaturation appropriately located based on the identity of R.sup.2, R.sup.3 and R.sup.4 and, R.sup.1 is alkyl, perfluoroalkyl, alkoxy, perfluoroalkoxy, alkylthio, perfluoroalkylthio, alkylsulfinyl, alkylamino, halo, alkanoyl, 1-hydroxyalkyl or (1-hydroxyimino) alkyl; R.sup.2 is hydrogen or alkyl; R.sup.3 is hydrogen or alkyl; R.sup.4 is hydrogen or alkyl; n is 0 or 1; or a pharmaceutically acceptable salt thereof, are antihyperglycemic agents.
REFERENCES:
patent: 3978077 (1976-08-01), Moller et al.
patent: 4099011 (1978-07-01), Moller et al.
patent: 4113957 (1978-09-01), Moller et al.
American Home Products Corporation
Jackson Richard K.
Ramsuer Robert W.
LandOfFree
Process for treating hyperglycemia using trifluoromethyl substit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for treating hyperglycemia using trifluoromethyl substit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for treating hyperglycemia using trifluoromethyl substit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849159